| Literature DB >> 30463235 |
Kaylee Rowland1, Perot Saelao2, Ying Wang3, Janet E Fulton4, Grant N Liebe5, Amy M McCarron6, Anna Wolc7,8, Rodrigo A Gallardo9, Terra Kelly10, Huaijun Zhou11, Jack C M Dekkers12, Susan J Lamont13.
Abstract
Newcastle disease is considered the number one disease constraint to poultry production in low and middle-income countries, however poultry that is raised in resource-poor areas often experience multiple environmental challenges. Heat stress has a negative impact on production, and immune response to pathogens can be negatively modulated by heat stress. Candidate genes and regions chosen for this study were based on previously reported associations with response to immune stimulants, pathogens, or heat, including: TLR3, TLR7, MX, MHC-B (major histocompatibility complex, gene complex), IFI27L2, SLC5A1, HSPB1, HSPA2, HSPA8, IFRD1, IL18R1, IL1R1, AP2A2, and TOLLIP. Chickens of a commercial egg-laying line were infected with a lentogenic strain of NDV (Newcastle disease virus); half the birds were maintained at thermoneutral temperature and the other half were exposed to high ambient temperature before the NDV challenge and throughout the remainder of the study. Phenotypic responses to heat, to NDV, or to heat + NDV were measured. Selected SNPs (single nucleotide polymorphisms) within 14 target genes or regions were genotyped; and genotype effects on phenotypic responses to NDV or heat + NDV were tested in each individual treatment group and the combined groups. Seventeen significant haplotype effects, among seven genes and seven phenotypes, were detected for response to NDV or heat or NDV + heat. These findings identify specific genetic variants that are associated with response to heat and/or NDV which may be useful in the genetic improvement of chickens to perform favorably when faced with pathogens and heat stress.Entities:
Keywords: Newcastle disease virus; commercial poultry; haplotype; heat stress; immune response
Year: 2018 PMID: 30463235 PMCID: PMC6267452 DOI: 10.3390/genes9110560
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Experimental design. NDV: Newcastle disease virus.
Gene, haplotype, and single nucleotide polymorphism (SNP) summary.
| Gene | Gene Name | Number of Haplotypes | Base Pairs 1 | Number of SNPs |
|---|---|---|---|---|
|
|
| 3 | 4819 | 21 |
|
|
| 3 | 1227 | 5 |
|
|
| 5 | 20,492 | 34 |
| MHC-B | Major histocompatibility complex B region 2 | 9 | 210,744 | 90 |
|
|
| 4 | 446 | 7 |
|
|
| 5 | 9763 | 8 |
|
|
| 2 | 1739 | 5 |
|
|
| 4 | 1364 | 5 |
|
|
| 7 | 5747 | 6 |
|
|
| 3 | 3774 | 3 |
|
|
| 3 | 6563 | 3 |
|
|
| 4 | 7979 | 7 |
|
|
| 9 | 45,285 | 15 |
|
|
| 4 | 26,625 | 14 |
1 Distance from first SNP to last SNP. 2 Gene complex encompassing 38 genes.
Heritability (h2) and descriptive statistics of phenotypes measured in both of the treatment groups and separately in response to NDV (Newcastle disease virus).
| Trait | Both Treatment Groups | NDV 3 | Heat + NDV 4 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| h2 (SE) | N | Mean | h2 (SE) | N | Mean | h2 (SE) | N | Mean | |
| Viral load 2 dpi 1 | 0.24 (0.06) | 969 | 4.94 | 0.32 (0.10) | 468 | 5.10 | 0.17 (0.10) | 501 | 4.77 |
| Viral load 6 dpi 1 | 0.09 (0.04) | 965 | 3.22 | 0.18 (0.10) | 470 | 3.72 | 0.11 (0.08) | 495 | 2.76 |
| Antibody 10 dpi 1 | 0.14 (0.05) | 916 | −0.07 | 0.24 (0.09) | 448 | −0.04 | 0.04 (0.06) | 468 | −0.10 |
| Growth rate pre-challenge 2 | 0.40 (0.06) | 991 | 8.62 | 0.46 (0.11) | 473 | 10.4 | 0.27 (0.09) | 518 | 6.93 |
| Growth rate post-challenge 2 | 0.16 (0.05) | 969 | 10.97 | 0.21 (0.09) | 470 | 15.4 | 0.11 (0.06) | 499 | 6.7 |
1 Phenotypes log10 transformed. 2 pre and post NDV challenge. 3 Referenced from [35]. 4 Referenced from [36]. SE: standard error.
Figure 2Viral load distributions at 2 and 6 dpi for both treatment groups.
Figure 3Antibody 10 dpi distribution by treatment group.
Figure 4Body weights on days 0, 21, and 31 and regression lines for population average growth rate pre- and post-NDV challenge by treatment group. Red boxes indicate the heat + NDV treatment group, blue boxes indicate the NDV treatment group.
p-values for genes with significant haplotype combination effects and for additive effects of individual haplotypes.
| Trait | Time Point | Analysis (Treatment Group) | Gene | Adjusted | Haplotype with Significant Additive Effect | Adjusted | ||
|---|---|---|---|---|---|---|---|---|
| Viral load | 6 days post NDV | combined |
| 0.001 | 0.014 | |||
| NDV |
| 0.01 | 0.14 | |||||
| Antibody | 10 days post NDV | combined |
| 0.002 | 0.028 | H03 1 | 0.003 | 0.18 |
| NDV |
| 0.01 | 0.14 | H03 1 | 0.001 | 0.06 | ||
| Growth rate | post heat and NDV | combined |
| 0.006 | 0.084 | |||
| NDV |
| 0.002 | 0.028 | H01 2 | 0.001 | 0.06 | ||
| heat + NDV |
| 0.001 | 0.014 | |||||
| BE | 9 days post heat; 2 days post NDV | heat + NDV |
| 0.001 | 0.014 | |||
| heat + NDV |
| 0.021 | 0.098 | |||||
| heat + NDV |
| 0.017 | 0.098 | |||||
| pH | 9 days post heat; 2 days post NDV | heat + NDV |
| 0.004 | 0.056 | |||
| heat + NDV |
| 0.011 | 0.077 | |||||
| HCO3 | 9 days post heat; 2 days post NDV | heat + NDV |
| 0.002 | 0.028 | |||
| TCO2 | 9 days post heat; 2 days post NDV | heat + NDV |
| 0.003 | 0.042 |
1IFI27L2-H03 defined in Table S6. 2IFRD1-H01 defined in Table S7.